KPIs & Operating Metrics(New)
Adjusted Admissions AnnualAdjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By SegmentAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Adjusted Patient AdmissionsAdjusted Patient Admissions AnnualAdjusted Patient DaysAdjusted Patient Days AnnualAdmissions Through Emergency DepartmentAdmissions Through Emergency Department AnnualAmbulatory Care Revenue By CategoryAmbulatory Care Revenue By Category AnnualAssets By SegmentAverage Length Of Stay (Days)Average Length Of Stay (Days) AnnualAverage Licensed BedsAverage Licensed Beds AnnualBreakdown Of AssetsCapital Expenditure By SegmentCharity And Uninsured AdmissionsCharity And Uninsured Admissions AnnualCharity And Uninsured Admissions As A Percentage Of Total Admissions Annual %Charity And Uninsured VisitsCharity And Uninsured Visits AnnualCharity And Uninsured Visits As A Percentage Of Total Visits Annual %Conifer Revenue By CategoryDeferred RevenueEmergency Department Admissions As A Percentage Of Total Admissions Annual %Emergency Department Visits AnnualEmergency Department Visits, OutpatientEmergency Department Visits, Outpatient AnnualEmployees By SegmentEmployee StatisticsLicensed Beds AnnualNet Patient Service Revenues From Hospitals And Related Outpatient FacilitiesNet Patient Service Revenues From Hospitals And Related Outpatient Facilities AnnualNet Patient Service Revenues Mix From Hospitals And Related Outpatient Facilities %Non Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Number Of Hospitals (At End Of Period)Number Of Hospitals (At End Of Period) AnnualOpex As A % Of Total Revenue %OPEX SegregationPatient Days — TotalPatient Days — Total AnnualPayer Mix By Total Admissions %Payer Mix By Total Admissions Annual %Paying Admissions As A Percentage Of Total Admissions Annual %Paying Admissions (Excludes Charity And Uninsured)Paying Admissions (Excludes Charity And Uninsured) AnnualPaying Visits As A Percentage Of Total Visits Annual %Paying Visits (Excludes Charity And Uninsured)Paying Visits (Excludes Charity And Uninsured) AnnualProperty And Equipment, Net BreakdownRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Surgeries — Inpatient AnnualSurgeries — Outpatient AnnualSurgery Visits AnnualTotal AdmissionsTotal Admissions AnnualTotal Consolidated CasesTotal Consolidated Cases AnnualTotal Consolidated Facilities (At End Of Period)Total Consolidated Facilities (At End Of Period) AnnualTotal Emergency Department VisitsTotal Emergency Department Visits AnnualTotal SurgeriesTotal Surgeries AnnualTotal VisitsTotal Visits AnnualUtilization Of Licensed Beds %Utilization Of Licensed Beds Annual %
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)Dividends Paid - Common (QoQ)Dividends Paid - Common Growth (1y)Dividends Paid - Common Growth (3y)Dividends Paid - Common Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio (QoQ)FCF Payout Ratio Growth (1y)FCF Payout Ratio Growth (3y)FCF Payout Ratio Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned
Tenet Healthcare (THC) EBITDA Margin (2016 - 2025)
Generated on {Timestamp}
© BusinessQuant.com
Generated on {Timestamp}
Powered by 
Tenet Healthcare's EBITDA Margin history spans 17 years, with the latest figure at 15.43% for Q4 2025.
- For Q4 2025, EBITDA Margin fell 73.0% year-over-year to 15.43%; the TTM value through Dec 2025 reached 16.46%, down 1235.0%, while the annual FY2025 figure was 19.73%, 1220.0% down from the prior year.
- EBITDA Margin for Q4 2025 was 15.43% at Tenet Healthcare, down from 16.81% in the prior quarter.
- Across five years, EBITDA Margin topped out at 61.2% in Q1 2024 and bottomed at 10.74% in Q4 2022.
- The 5-year median for EBITDA Margin is 14.28% (2022), against an average of 16.79%.
- The largest annual shift saw EBITDA Margin surged 4919bps in 2024 before it tumbled -4314bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 15.47% in 2021, then crashed by -31bps to 10.74% in 2022, then grew by 27bps to 13.62% in 2023, then increased by 19bps to 16.17% in 2024, then fell by -5bps to 15.43% in 2025.
- Per Business Quant, the three most recent readings for THC's EBITDA Margin are 15.43% (Q4 2025), 16.81% (Q3 2025), and 15.61% (Q2 2025).
Peer Comparison
Historic Data
Download Data 🔒| Date | Value |
|---|---|